Close
CDMO Safety Testing 2026
Novotech

The 2011 Universal Biotech Innovation Prize was awarded to the French company MTP Therapeutics during the event on the 27th of September 2011, in Paris.

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...
- Advertisement -

Open to young innovative companies, to academic and private researchers, the Universal Biotech Innovation Prize is aimed at acknowledging, on an International level, the best innovations within two selected areas: Innovative Therapy and Medical Device. For this third edition, 86 projects from 13 European countries were reviewed and evaluated according to precise criteria, defined by a jury panel made up of well recognized figures from pharmaceutical industry and European institutions, and chaired by Jean Deregnaucourt, Executive Vice President of Business Development at Institut Pasteur. The jury members paid particular attention to the scientific quality of the innovations, their intellectual and industrial property protection as well as their development strategy. First, 15 applicants were provisionally selected and amongst them 4 finalists were chosen.

Le 2011 Universal Biotech Innovation global Prize of 50.000 € (including cash and services), was awarded to the French company MTP Therapeutics(1) for having developed a new anti-cancer drug for the treatment of solid tumors. The lead compound, called pTM-NRP1, targets Neuropilin-1 receptor and co-receptors which have a pivotal role in endothelial and tumour cell migration. The innovative potential, the interest of the finding and the strength of the industrial property have rewarded the work of this French research team.

The mobilization of the jury members and the support of the industrial and institutional partners contributed to the success of the 2011 Innovation Prize, meeting the initial objective, i.e. the promotion and the development of winning alliances between biopharmaceutical public and private sectors.

The awarding ceremony was held in Paris, during the Innovation Days on the 27th of September 2011. The event, dedicated to the promotion of biomedical research, gathered about 450 participants and 54 speakers, leading conferences, round tables and workshops. Following the success of the 2011 edition, the 3rd edition of Innovation Days will take place at the CitΓ© Internationale Universitaire of Paris, on October, 1st, 2nd and 3rd 2012.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast – stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Agilent, Veeda Lifesciences Launch Biopharma Analytics Hub

Agilent Technologies and Veeda Lifesciences have announced a strategic...

Shilpa Medicare, NXI Therapeutics AG Enters Partnership

A long-term development and commercial manufacturing agreement has been...

Cantex and Headlamp Target MS Depression Using Lumos AI

Cantex Pharmaceuticals and Headlamp Health have entered a collaboration...

VoxCell and adMare Partner on Antibody Therapy Research

VoxCell BioInnovation Inc. and adMare BioInnovations have entered a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate Β»